BrainStorm just announced that it has secured an FDA advisory committee vote for treatment candidate NurOwn for the treatment of ALS. NurOwn’s results on biomarker NfL in combination with other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results